The pharmacokinetics of a B-domain truncated recombinant factor VIII, turoctocog alfa (NovoEight®), in patients with hemophilia A.
about
Updates from guardian™: a comprehensive registration programme.Elucidation of Factor VIII Activity Pharmacokinetics: A Pooled Population Analysis in Patients With Hemophilia A Treated With Moroctocog Alfa.Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A.The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A.
P2860
The pharmacokinetics of a B-domain truncated recombinant factor VIII, turoctocog alfa (NovoEight®), in patients with hemophilia A.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The pharmacokinetics of a B-do ...... in patients with hemophilia A.
@en
type
label
The pharmacokinetics of a B-do ...... in patients with hemophilia A.
@en
prefLabel
The pharmacokinetics of a B-do ...... in patients with hemophilia A.
@en
P2093
P2860
P921
P356
P1476
The pharmacokinetics of a B-do ...... in patients with hemophilia A.
@en
P2093
E Santagostino
R Klamroth
S Lejniece
T Saugstrup
P2860
P304
P356
10.1111/JTH.12816
P577
2015-02-13T00:00:00Z